Abstract:Astrocytes are the most abundant type of glial cell in the central nervous system. Upon injury and inflammation, astrocytes become reactive and undergo morphological and functional changes. Depending on their phenotypic classification as A1 or A2, reactive astrocytes contribute to both neurotoxic and neuroprotective responses, respectively. However, this binary classification does not fully capture the diversity of astrocyte responses observed across different diseases and injuries. Transcriptomic analysis has revealed that reactive astrocytes have a complex landscape of gene expression profiles, which emphasizes the heterogeneous nature of their reactivity. Astrocytes actively participate in regulating central nervous system inflammation by interacting with microglia and other cell types, releasing cytokines, and influencing the immune response. The phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT) signaling pathway is a central player in astrocyte reactivity and impacts various aspects of astrocyte behavior, as evidenced by in silico , in vitro , and in vivo results. In astrocytes, inflammatory cues trigger a cascade of molecular events, where nuclear factor-κB serves as a central mediator of the pro-inflammatory responses. Here, we review the heterogeneity of reactive astrocytes and the molecular mechanisms underlying their activation. We highlight the involvement of various signaling pathways that regulate astrocyte reactivity, including the PI3K/AKT/mammalian target of rapamycin (mTOR), α v β 3 integrin/PI3K/AKT/connexin 43, and Notch/PI3K/AKT pathways. While targeting the inactivation of the PI3K/AKT cellular signaling pathway to control reactive astrocytes and prevent central nervous system damage, evidence suggests that activating this pathway could also yield beneficial outcomes. This dual function of the PI3K/AKT pathway underscores its complexity in astrocyte reactivity and brain function modulation. The review emphasizes the importance of employing astrocyte-exclusive models to understand their functions accurately and these models are essential for clarifying astrocyte behavior. The findings should then be validated using in vivo models to ensure real-life relevance. The review also highlights the significance of PI3K/AKT pathway modulation in preventing central nervous system damage, although further studies are required to fully comprehend its role due to varying factors such as different cell types, astrocyte responses to inflammation, and disease contexts. Specific strategies are clearly necessary to address these variables effectively.

The dual role of astrocyte activation and reactive gliosis

Astrocytes: biology and pathology

Impacts of PI3K/protein kinase B pathway activation in reactive astrocytes: from detrimental effects to protective functions

Protective Functions of Reactive Astrocytes Following Central Nervous System Insult

Reactive Gliosis in Neonatal Disorders: Friend or Foe for Neuroregeneration?

Reactive and Senescent Astroglial Phenotypes as Hallmarks of Brain Pathologies

Reactive Astrocytes in Neurodegenerative Diseases

Astrocytes: a double-edged sword in neurodegenerative diseases

Astroglial activation: Current concepts and future directions

Functional roles of reactive astrocytes in neuroinflammation and neurodegeneration

Astrocyte-Mediated Neuroinflammation in Neurological Conditions

Astrocytes in human central nervous system diseases: a frontier for new therapies

Reactive astrogliosis in the era of single-cell transcriptomics

Astrocyte Regulation of Neuronal Function and Survival in Stroke Pathophysiology

Reciprocal Modulation Between Microglia and Astrocyte in Reactive Gliosis Following the CNS Injury

Altered Homeostatic Functions in Reactive Astrocytes and Their Potential as a Therapeutic Target After Brain Ischemic Injury

Reactive astrocytes generated from human iPSC are pro-inflammatory and display altered metabolism

Neurotoxic reactive astrocytes are induced by activated microglia

Insight into Astrocyte Activation after Optic Nerve Injury

Functions of Astrocytes under Normal Conditions and after a Brain Disease

Genomic analysis of reactive astrogliosis